Hiroyuki Yamaguchi

10PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyPredictive and prognostic markersChemotherapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 25, 2022
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer.

Satomi Tanaka, Junji Uchino, Takashi Yokoi

|Sep 28, 2021
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

Yosuke Dotsu, Hiroyuki Yamaguchi, Minoru Fukuda

|Jul 13, 2021
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.

Shinnosuke Takemoto, Kazumasa Akagi, Sawana Ono

|Dec 03, 2020
Pneumoconiosis with a Sarcoid-Like Reaction Other than Beryllium Exposure: A Case Report and Literature Review.

Fumiko Hayashi, Takashi Kido, Noriho Sakamoto

|Jan 08, 2020
Vildagliptin-induced ground-glass nodules mimicking lung metastases in a cancer patient receiving Lactobacillus probiotic supplementation.

Yasuhiro Tanaka, Hiroshi Soda, Yuichi Fukuda

|Dec 19, 2019
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.

Shinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi

Pageof 2

Frequent Collaborators

5 joint publications

Minoru Fukuda

4 joint publications

Hiroshi Soda

4 joint publications

Shinnosuke Takemoto

3 joint publications

Takaya Ikeda